According to a leaked government document detailing Operation Yellowhammer, the UK's preparation guide to a no-deal Brexit, there will likely be a shortage of food and medicine and a hard Irish border, the Sunday Times reported on Sunday.
Reporting on the matter, "The documents predict severe extended delays to medicine supplies and shortages of some fresh foods combined with price rises as a likely scenario if the UK leaves without a withdrawal agreement, which is due to happen on 31 October," The Guardian's Rowena Mason wrote.
Although Downing Street sources refrained from commenting on the leaked document, they acknowledged the fact that it was prepared when Theresa May was the Prime Minister, confirming its existence.
The British pound finished the week as the best performing G10 currency supported by upbeat employment and retails sales data from the UK but could start the new week under pressure following this development.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.